Frontlight ResearchEarly access
Trial site
Institute for Treatment and Rehabilitation, Niska Banja
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Heart failure4 trials
- Coronary artery disease2 trials
- Atrial fibrillation1 trial
- High blood pressure1 trial
- Osteoporosis1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Rheumatoid arthritis1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Boehringer Ingelheim4 trials
- Janssen Research & Development, LLC3 trials
- Alfasigma S.p.A.1 trial
- Corteria Pharmaceuticals1 trial
- Enzene Biosciences Ltd.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- High blood pressure1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026